Apr 2 |
NEW REPORT SUPPORTS USE OF CALDOLORĀ® AS A STANDARD OF CARE ACROSS PATIENT POPULATIONS
|
Mar 6 |
Q4 2023 Cumberland Pharmaceuticals Inc Earnings Call
|
Mar 6 |
Cumberland Pharmaceuticals Inc. (CPIX) Q4 2023 Earnings Call Transcript
|
Mar 5 |
Cumberland Pharmaceuticals Non-GAAP EPS of $0.17, revenue of $40M
|
Mar 5 |
Cumberland Pharmaceuticals Reports Annual 2023 Financial Results
|
Mar 5 |
Earnings Scheduled For March 5, 2024
|
Nov 12 |
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q3 2023 Earnings Call Transcript
|
Nov 11 |
Cumberland Pharmaceuticals Inc. (CPIX) Q3 2023 Earnings Call Transcript
|
Nov 11 |
Cumberland Pharmaceuticals Inc. 2023 Q3 - Results - Earnings Call Presentation
|
Nov 7 |
Cumberland Pharmaceuticals Non-GAAP EPS of $0.02, revenue of $10.1M
|